ERG and posterior cortical atrophy: A clinical trial conducted by Jewish General Hospital, Quebec, Canada, recruited 65 high-risk PCa patients treated with radiation and hormonal therapy after biochemical failure to evaluate the predictive value of TMPRSS2–ERG gene fusion (ClinicalTrials.gov Identifier: NCT02588404).